Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $131K invested in Moleculin Biotech in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citigroup
New York
|
+$24.9K |
2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.9K |
3 |
VF
Virtu Financial
New York
|
+$18K |
4 |
VCP
Verus Capital Partners
Scottsdale,
Arizona
|
+$13K |
5 |
LPL Financial
San Diego,
California
|
+$3.02K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$1.22M |
2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$68.2K |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$33 |